Eric Adams
Net worth: 2 966 $ as of 2026-08-30
Net worth: 2 966 $ as of 2026-08-30
Mr. Eric A. Adams is a President, Chief Executive Officer & Director at InMed Pharmaceuticals, Inc. He is on the Board of Directors at InMed Pharmaceuticals, Inc. Mr. Adams was previously employed as a Chief Executive Officer by Ronin8 Technologies Ltd., a Non-Executive Director by enGene, Inc., a Director-Oncology Marketing by QLT, Inc., a Senior Manager-Business Development by Abbott Laboratories, and a Country Manager by Fresenius SE.
He received his undergraduate degree from the University of Southern Indiana and a graduate degree from the University of South Carolina.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2025-12-18 | 2,197 ( 0.07% ) | 2 966 $ | 2026-08-30 |
| Companies | Position | Start |
|---|---|---|
| INMED PHARMACEUTICALS INC. | Chief Executive Officer | 2016-06-15 |
| Companies | Position | End |
|---|---|---|
Ronin8 Technologies Ltd.
Ronin8 Technologies Ltd. Environmental ServicesIndustrial Services Operates a materials recovery facility | Chief Executive Officer | 2015-01-31 |
enGene, Inc.
enGene, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company, which develops non-viral gene therapies | Chief Executive Officer | 2013-06-30 |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and markets ocular products | Sales & Marketing | 2002-11-30 |
| ABBOTT LABORATORIES | Corporate Officer/Principal | 1996-07-31 |
| FRESENIUS SE & CO. KGAA | Corporate Officer/Principal | 1992-05-31 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 8 |
|---|---|
Abbott Laboratories
Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA Hospital/Nursing ManagementHealth Services Develops and manufactures generic drugs, biopharmaceuticals, infusion & nutrition therapies and medical devices | Health Services |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and markets ocular products | Commercial Services |
InMed Pharmaceuticals, Inc.
InMed Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures prescription-based products for dermatology and ocular diseases | Health Technology |
enGene, Inc.
enGene, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company, which develops non-viral gene therapies | Health Technology |
University of South Carolina
University of South Carolina Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Southern Indiana
University of Southern Indiana Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ronin8 Technologies Ltd.
Ronin8 Technologies Ltd. Environmental ServicesIndustrial Services Operates a materials recovery facility | Industrial Services |
Select your edition
All financial news and data tailored to specific country editions